Plasma levels and estimated dopamine D2 receptor occupancy of long-acting injectable risperidone during maintenance treatment of schizophrenia: a 3-year follow-up study-Reference-Cited by-同舟云学术

Plasma levels and estimated dopamine D2 receptor occupancy of long-acting injectable risperidone during maintenance treatment of schizophrenia: a 3-year follow-up study

Published:2016-09-08 Issue:23-24 Volume:233 Page:4003-4010
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Ikai Saeko,Suzuki Takefumi,Mimura Masaru,Uchida Hiroyuki

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s00213-016-4428-1.pdf

Reference36 articles.

1. Barnes TR (1989) A rating scale for drug-induced akathisia. Brit J Psychiat 154:672–676

2. Castberg I, Spigset O (2005) Serum concentrations of risperidone and 9-hydroxyrisperidone after administration of the long-acting injectable form of risperidone: evidence from a routine therapeutic drug monitoring service. Ther Drug Monit 27:103–106

3. Chue P, Emsley R (2007) Long-acting formulations of atypical antipsychotics: time to reconsider when to introduce depot antipsychotics. CNS Drugs 21:441–448

4. Corena-McLeod M (2015) Comparative pharmacology of risperidone and paliperidone. Drugs in R&D 15:163–174. doi: 10.1007/s40268-015-0092-x

5. Deslandes PN, Lewis A, Thomas A, Sewell RD (2009) Risperidone long acting injection: findings of a 2-year retrospective follow-up study. Int J Psychiatry Clin Pract 13:298–302. doi: 10.3109/13651500903046286

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Longitudinal changes in clozapine dose in patients with treatment-resistant schizophrenia: a 5-year retrospective cohort study;International Clinical Psychopharmacology;2022-09-15

2. Schizophrenia and Related Psychoses;The Maudsley Prescribing Guidelines in Psychiatry;2021-12-02

3. The Relation between the Plasma Concentrations of Long-Acting Atypical Antipsychotics and Clinical Effectiveness in Patients Affected by Schizophrenia or Schizoaffective Disorder: A Comprehensive Overview;Current Pharmaceutical Design;2021-10-26

4. Longitudinal changes in antipsychotic dose in patients treated with long-acting injectable second-generation antipsychotics;International Clinical Psychopharmacology;2020-01-22

5. Cancer and the Dopamine D2Receptor: A Pharmacological Perspective;Journal of Pharmacology and Experimental Therapeutics;2019-04-18